• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.混合性或重叠性骨髓增生异常/骨髓增殖性疾病——流行病学特征与概述
Front Oncol. 2021 Nov 16;11:778741. doi: 10.3389/fonc.2021.778741. eCollection 2021.
2
Myelodysplastic/myeloproliferative neoplasms.骨髓增生异常/骨髓增殖性肿瘤。
Semin Diagn Pathol. 2011 Nov;28(4):283-97. doi: 10.1053/j.semdp.2011.07.002.
3
Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征的临床管理
Cancer Biol Med. 2016 Sep;13(3):360-372. doi: 10.20892/j.issn.2095-3941.2016.0043.
4
Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.骨髓增生异常综合征/骨髓增生性肿瘤重叠综合征的基因组学。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):450-459. doi: 10.1182/hematology.2020000130.
5
An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.外推法的实践:非典型慢性粒细胞白血病、无法分类的骨髓增生异常综合征/骨髓增殖性肿瘤及伴有环形铁粒幼细胞的骨髓增生异常综合征/骨髓增殖性肿瘤的临床管理
Curr Hematol Malig Rep. 2016 Dec;11(6):425-433. doi: 10.1007/s11899-016-0350-1.
6
Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.诊断骨髓增生异常/骨髓增殖性肿瘤:排除其他疾病的实验室检测策略。
Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x.
7
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.非典型慢性髓系白血病和未另行指定的骨髓增生异常/骨髓增殖性肿瘤:2023年诊断、风险分层及管理更新
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
8
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征:重点综述。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163.
9
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review.2022年世界卫生组织(WHO)和国际癌症研究机构(ICC)时代的骨髓增生异常综合征/骨髓增殖性重叠肿瘤及其鉴别诊断:重点综述
Cancers (Basel). 2023 Jun 13;15(12):3175. doi: 10.3390/cancers15123175.
10
Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.骨髓增生异常/骨髓增殖性肿瘤的基因组景观:一项多中心研究。
Int J Mol Sci. 2024 Sep 23;25(18):10214. doi: 10.3390/ijms251810214.

引用本文的文献

1
Clinical management of CMML-State of the art.慢性粒单核细胞白血病的临床管理——最新进展
Br J Haematol. 2025 Aug;207(2):350-364. doi: 10.1111/bjh.20213. Epub 2025 Jun 24.
2
Severe Acute Kidney Injury Associated with Transformation of Chronic Myelomonocytic Leukemia into Acute Myeloid Leukemia: A Case Report.慢性粒单核细胞白血病转化为急性髓系白血病相关的严重急性肾损伤:一例报告
J Clin Med. 2024 Jan 16;13(2):494. doi: 10.3390/jcm13020494.
3
Polycythemia Vera: Thinking Beyond the Hematocrit.真性红细胞增多症:超越血细胞比容的思考
J Adv Pract Oncol. 2023 Jul;14(5):405-413. doi: 10.6004/jadpro.2023.14.5.5. Epub 2023 Jul 1.

本文引用的文献

1
Prognostic significance of isochromosome 17q in hematologic malignancies.17号染色体等臂染色体在血液系统恶性肿瘤中的预后意义
Oncotarget. 2021 Mar 30;12(7):708-718. doi: 10.18632/oncotarget.27914.
2
Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.骨髓增生异常综合征/骨髓增生性肿瘤重叠综合征的基因组学。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):450-459. doi: 10.1182/hematology.2020000130.
3
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.非典型慢性髓性白血病的综合基因组、功能和预后特征分析
Hemasphere. 2020 Nov 6;4(6):e497. doi: 10.1097/HS9.0000000000000497. eCollection 2020 Dec.
4
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype.具有骨髓增殖性肿瘤和慢性粒单核细胞白血病样表型患者的临床、血液学、生物学及分子特征
Cancers (Basel). 2020 Jul 14;12(7):1891. doi: 10.3390/cancers12071891.
5
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.成人骨髓增生异常/骨髓增殖性肿瘤的分子特征和克隆结构。
Blood. 2020 Oct 15;136(16):1851-1862. doi: 10.1182/blood.2019004229.
6
Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.寡单核细胞性 CMML 及其他 CMML 前状态:临床影响、预后和管理。
Best Pract Res Clin Haematol. 2020 Jun;33(2):101137. doi: 10.1016/j.beha.2019.101137. Epub 2019 Dec 15.
7
Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.慢性髓单核细胞白血病:诊断、危险分层和治疗的 2020 年更新。
Am J Hematol. 2020 Jan;95(1):97-115. doi: 10.1002/ajh.25684.
8
Characteristics and survival of patients with atypical chronic myeloid leukemia.非典型慢性髓系白血病患者的特征与生存情况
Blood Res. 2019 Sep;54(3):233-236. doi: 10.5045/br.2019.54.3.233. Epub 2019 Sep 25.
9
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet.成人慢性粒单核细胞白血病的诊断与治疗:欧洲血液学协会和欧洲白血病网的建议
Hemasphere. 2018 Nov 29;2(6):e150. doi: 10.1097/HS9.0000000000000150. eCollection 2018 Dec.
10
Myeloid neoplasms with isolated del(5q) and V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features?伴有孤立性5号染色体长臂缺失(del(5q))和V617F突变的髓系肿瘤:一种具有骨髓增生异常和骨髓增殖性特征的“灰色地带”组合?
Haematologica. 2020 Jun;105(6):e276-e279. doi: 10.3324/haematol.2019.227686. Epub 2019 Sep 26.

混合性或重叠性骨髓增生异常/骨髓增殖性疾病——流行病学特征与概述

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.

作者信息

Kuendgen Andrea, Kasprzak Annika, Germing Ulrich

机构信息

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Hospital Duesseldorf, Duesseldorf, Germany.

出版信息

Front Oncol. 2021 Nov 16;11:778741. doi: 10.3389/fonc.2021.778741. eCollection 2021.

DOI:10.3389/fonc.2021.778741
PMID:34869027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8635204/
Abstract

The WHO-category Myelodysplastic/Myeloproliferative neoplasms (MDS/MPNs) recognizes a unique group of clonal myeloid malignancies exhibiting overlapping features of myelodysplastic as well as myeloproliferative neoplasms. The group consists of chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia, -negative (aCML), juvenile myelomonocytic leukemia (JMML), myelodysplastic/myeloproliferative neoplasm with ringed sideroblasts and thrombocytosis (MDS/MPN-RS-T), and myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U). The most frequent entity in this category is CMML, while all other diseases are extremely rare. Thus, only very limited data on the epidemiology of these subgroups exists. An appropriate diagnosis and classification can be challenging since the diagnosis is still largely based on morphologic criteria and myelodysplastic as well as myeloproliferative features can be found in various occurrences. The diseases in this category share several features that are common in this specific WHO-category, but also exhibit specific traits for each disease. This review summarizes published data on epidemiological features and offers a brief overview of the main diagnostic criteria and clinical characteristics of the five MDS/MPN subgroups.

摘要

世界卫生组织(WHO)分类中的骨髓增生异常/骨髓增殖性肿瘤(MDS/MPNs)是一组独特的克隆性髓系恶性肿瘤,具有骨髓增生异常和骨髓增殖性肿瘤的重叠特征。该组包括慢性粒单核细胞白血病(CMML)、非典型慢性髓系白血病(aCML)、幼年型粒单核细胞白血病(JMML)、伴有环形铁粒幼细胞和血小板增多的骨髓增生异常/骨髓增殖性肿瘤(MDS/MPN-RS-T)以及无法分类的骨髓增生异常/骨髓增殖性肿瘤(MDS/MPN-U)。该类别中最常见的类型是CMML,而其他所有疾病都极为罕见。因此,关于这些亚组流行病学的资料非常有限。由于诊断仍主要基于形态学标准,且在不同病例中均可发现骨髓增生异常及骨髓增殖性特征,所以做出恰当的诊断和分类颇具挑战性。该类别中的疾病具有一些在WHO这一特定分类中常见的特征,但每种疾病也有其特定的特点。本综述总结了已发表的关于流行病学特征的数据,并简要概述了五个MDS/MPN亚组的主要诊断标准和临床特征。